2
Views
2
CrossRef citations to date
0
Altmetric
Cell Growth and Development

A Novel c-fgr Exon Utilized in Epstein-Barr Virus-Infected B Lymphocytes but Not in Normal Monocytes

, , , , , & show all
Pages 1500-1507 | Received 16 Aug 1990, Accepted 19 Dec 1990, Published online: 31 Mar 2023

REFERENCES

  • Bodine, D. M., and T. J. Ley. 1987. An enhancer element lies 3′ to the human γ-globin gene. EMBO J. 6:2997-3004.
  • Cheah, M. S. C., T. J. Ley, S. R. Tronick, and K. C. Robbins. 1986. fgr proto-oncogene mRNA induced in B-lymphocytes by Epstein-Barr virus infection. Nature (London) 319:238-240.
  • Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
  • Clements, G. B., G. Klein, and S. Povey. 1975. Production by EBV infection of an EBNA-positive subline from an EBNA- negative human lymphoma cell line without detectable EBV DNA. Int. J. Cancer 15:125-133.
  • Deininger, P. L., and C. W. Schmid. 1979. A study of the evolution of repeated DNA sequences in primates and the existence of a new class of repetitive sequences in primates. J. Mol. Biol. 127:437-460.
  • Fahey, J. L., D. N. Buell, and H. C. Sox. 1971. Proliferation and differentiation of lymphoid cell lines and immunoglobulin synthesis. Ann. N.Y. Acad. Sci. 190:221-234.
  • Favaloro, J., R. Treisman, and R. Kamen. 1980. Transcription maps of polyoma specific RNA analysis by two-dimensional nuclease S1 gel mapping. Methods Enzymol. 65:618-749.
  • Gutkind, J. S., and K. C. Robbins. 1989. Translocation of the c-fgr protein-tyrosine kinase as a consequence of neutrophil activation. Proc. Natl. Acad. Sci. USA 86:8783-8787.
  • Hunter, T., and J. A. Cooper. 1985. Protein-tyrosine kinases. Annu. Rev. Biochem. 54:897-930.
  • Inoue, K., S. Ikawa, K. Semba, J. Sukegawa, T. Yamomoto, and K. Toyoshima. 1987. Isolation and sequencing of cDNA clones homologous to the v-fgr oncogene from a human B-lymphocyte cell line, IM-9. Oncogene 1:301-304.
  • Inoue, K., T. Yamamoto, and K. Toyoshima. 1990. Specific expression of human c-fgr in natural immunity effector cells. Mol. Cell. Biol. 10:1789-1792.
  • Jainchill, J. L., S. A. Aaronson, and G. J. Todaro. 1969. Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells. J. Virol. 4:549-553.
  • Katamine, S., V. Notario, C. R. Rao, T. Miki, M. S. C. Cheah, S. R. Tronick, and K. C. Robbins. 1988. Primary structure of the human fgr proto-oncogene product p55c-fgr. Mol. Cell. Biol. 8:259-266.
  • Klein, G., B. Giovanella, A. Westman, J. S. Stehlin, and D. Mumford. 1975. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology 5:319-334.
  • Knutson, J. C. 1990. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization. J. Virol. 64:2530-2536.
  • Ley, T. J., N. L. Connolly, S. Katamine, M. S. C. Cheah, R. M. Senior, and K. C. Robbins. 1989. Tissue-specific expression and developmental regulation of the human fgr proto-oncogene. Mol. Cell. Biol. 9:92-99.
  • Link, D. C., J. S. Gutkind, K. C. Robbins, and T. J. Ley. Unpublished data.
  • Miki, T., T. Matsui, M. A. Heidaran, and S. A. Aaronson. 1989. An efficient directional cloning system to construct cDNA libraries containing full-length inserts at high frequency. Gene 83:137-146.
  • Naharro, G., K. C. Robbins, and E. P. Reddy. 1984. Gene product of N-fgr one: hybrid protein containing a portion of actin and a tyrosine-specific protein kinase. Science 233:63-66.
  • Notario, V., J. S. Gutkind, M. Imaizumi, S. Katamine, and K. C. Robbins. 1989. Role for the fgr proto-oncogene in programmed differentiation of myelomonocytic cells. J. Cell Biol. 109:3129-3136.
  • Patel, M., S. J. Leevers, and P. M. Brickell. 1990. Structure of the complete human c-fgr proto-oncogene and identification of multiple transcriptional start sites. Oncogene 5:201-206.
  • Rasheed, S., M. Barbacid, S. A. Aaronson, and M. B. Gardner. 1982. Origin and biological properties of a new feline sarcoma virus. Virology 117:238-244.
  • Reynolds, P. J., J. Lesley, J. Trotter, R. Schulte, R. Hyman, and B. M. Sefton. 1990. Changes in the relative abundance of type I and type II lck mRNA transcripts suggest differential promoter usage during T-cell development. Mol. Cell. Biol. 10:4266-4270.
  • Sartor, O., F. S. Gregory, N. S. Templeton, S. Pawar, R. M. Perlmutter, and N. Rosen. 1989. Selective expression of alternative lck mRNAs in human malignant cell lines. Mol. Cell. Biol. 9:2983-2988.
  • Sugita, K., J. S. Gutkind, S. Katamine, T. Kawakami, and K. C. Robbins. 1989. The actin domain of Gardner-Rasheed feline sarcoma virus inhibits tyrosine kinase and transforming activities. J. Virol. 63:1715-1720.
  • Takadera, T., S. Leung, A. Gernone, Y. Koga, Y. Takihara, N. G. Miyamoto, and T. W. Mak. 1989. Structure of the two promoters of the human lek gene: differential accumulation of two classes of lck transcripts in T cells. Mol. Cell. Biol. 9:2173-2180.
  • Ulrich, M. J., and T. J. Ley. 1990. Function of normal and mutated 7-globin gene promoters in electroporated K562 erythroleukemia cells. Blood 75:990-999.
  • Voronova, A. F., H. T. Adler, and B. M. Sefton. 1987. Two lek transcripts containing different 5′ untranslated regions are present in T cells. Mol. Cell. Biol. 7:4407-4413.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.